The proposed regulation of software as a medical device by Australia's Therapeutic Goods Administration has been rejected outright by the local industry, which cites the RACGP and Pharmacy Guild as supporting its stance.

The TGA is currently holding consultations on the regulation of software as a medical device (SaMD) in light of the explosion of health apps, artificial intelligence and machine learning in diagnostic software and its potential effect on patient safety.